News
A new collaboration between Apertura and the National Institutes of Health (NIH) aims to advance a potential gene therapy for Niemann-Pick Disease Type C1 (NPC1), a rare and often fatal neurodegenerative disorder. Under a newly signed Cooperative Research and Development Agreement (CRADA), NIH and
Two NIH Technology Transfer experts are headed to Philadelphia for the BioTechX conference taking place September 16-17, 2025. Steve Ferguson, Special Advisor in the NIH Office of Technology Transfer will be speaking on the Partnering with NIH in the Rare Disease Landscape panel on September 16th
Register for a free NIH technology webinar to learn about a potential, novel treatment for Triple Negative Breast Cancer (TNBC). William Reinhold and his team at the National Cancer Institute repurposed two separate therapeutic compounds ─ acetalax and bisacodyl (both previously used as laxatives) ─
Meet with a NIH Technology Transfer expert at The Maryland Tech Council’s Bio Innovation Conference on September 4th. This event brings together the region’s top life sciences professionals with global industry leaders, venture capitalists, and innovative startups. NIH Technology Transfer is always